Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. (Q51023029)

27 March 2018

title

Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. (English)

1 reference

27 March 2018

0 references

Jinoh Kim

1

1 reference

27 March 2018

Jane A Gross

2

1 reference

27 March 2018

Stacey R Dillon

3

1 reference

27 March 2018

Jun-Ki Min

4

1 reference

27 March 2018

Keith B Elkon

5

1 reference

27 March 2018

publication date

20 January 2011

1 reference

27 March 2018

published in

Autoimmunity

1 reference

27 March 2018

volume

44

1 reference

27 March 2018

issue

2

1 reference

27 March 2018

page(s)

69-81

1 reference

27 March 2018

Nature and functions of autoantibodies

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BAFF AND APRIL: a tutorial on B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Identification of proteoglycans as the APRIL-specific binding partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

TACI and BAFF-R mediate isotype switching in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BCMA is essential for the survival of long-lived bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

The BAFF/APRIL system: an important player in systemic rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BlySfulness does not equal blissfulness in systemic lupus erythematosus: a therapeutic role for BLyS antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

An APRIL to remember: novel TNF ligands as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Regulated expression of BAFF-binding receptors during human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Identification and characterization of circulating human transitional B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Peripheral development of B cells in mouse and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

CpG drives human transitional B cells to terminal differentiation and production of natural antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

BAFF and MyD88 signals promote a lupuslike disease independent of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

An open study of B lymphocyte depletion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Long-lived plasma cells and their contribution to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2010.509122

10.3109/08916934.2010.509122

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018